Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Clinical trial NCT06456593 · RECRUITING
Trial details
- NCT number
- NCT06456593
- Sponsor
- Abivax S.A.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2026-12-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.